Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sara M Federico
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Children'S Hospital at Westmead
Westmead, New South Wales, Australia
- Royal Children'S Hospital
Parkville, Victoria, Australia
- Starship Children'S Hospital
Grafton, Auckland, New Zealand
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Nyp/columbia University Medical Center/herbert Irving Comprehensive Cancer Center
New York, New York, United States
- Children'S Hospital of Pittsburgh of Upmc
Pittsburgh, Pennsylvania, United States
- Saint Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Primary Children'S Hospital
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Mar 2019
- Primary completion
- 31 Dec 2021
- Completion
- 31 Mar 2026
- Last update posted
- 2 Jun 2026
- Registered enrollment
- 42
- Registry id
- NCT03786783
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.